Effects of low dose pirfenidone on lung function for patients with idiopathic pulmonary fibrosis in real practice

被引：0
|
作者：
Moon, K. M. [1 ]
Jung, B. [1 ]
Lee, J. G. [1 ]
Kim, M. P. [1 ]
机构：
[1] Univ Ulsan, Gangneung Asan Hosp, Coll Med, Dept Pulm Allergy & Crit Care Med, 38 Bangdong Gil, Gangneung Si 25440, Gangwon Do, South Korea
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.2750
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2750
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study
    Lee, Eung Gu
    Lee, Tae-Hee
    Hong, Yujin
    Ryoo, Jiwon
    Heo, Jung Won
    Gil, Bo Mi
    Kang, Hye Seon
    Kwon, Soon Seog
    Kim, Yong Hyun
    [J]. PLOS ONE, 2021, 16 (12):
  • [2] Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study
    Lee, Eung Gu
    Lee, Tae-Hee
    Hong, Yujin
    Ryoo, Jiwon
    Heo, Jung Won
    Kang, Hye Seon
    Kwon, Soon Seog
    Kim, Yong Hyun
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [3] Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
    Albera, Carlo
    Costabel, Ulrich
    Fagan, Elizabeth A.
    Glassberg, Marilyn K.
    Gorina, Eduard
    Lancaster, Lisa
    Lederer, David J.
    Nathan, Steven D.
    Spirig, Dominique
    Swigris, Jeff J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) : 843 - 851
  • [4] Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment
    Nathan, Steven D.
    Costabel, Ulrich
    Albera, Carlo
    Behr, Juergen
    Wuyts, Wim A.
    Kirchgaessler, Klaus-Uwe
    Stauffer, John L.
    Morgenthien, Elizabeth
    Chou, Willis
    Limb, Susan L.
    Noble, Paul W.
    [J]. RESPIRATORY MEDICINE, 2019, 153 : 44 - 51
  • [5] Efficacy of lower dose pirfenidone for idiopathic pulmonary fibrosis in real practice: a retrospective cohort study
    Hwang, Hyeontaek
    Lee, Jung-Kyu
    Choi, Sun Mi
    Lee, Yeon Joo
    Cho, Young-Jae
    Yoon, Ho Il
    Lee, Jae Ho
    Lee, Choon-Taek
    Kim, Young Whan
    Park, Jong Sun
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, 37 (02): : 366 - 376
  • [6] SINGLE CENTRE EXPERIENCE OF THE REAL-LIFE IMPACT OF PIRFENIDONE ON LUNG FUNCTION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Rathnapala, A.
    Fries, A.
    West, Y.
    Ho, L. P.
    Hoyles, R. K.
    [J]. THORAX, 2016, 71 : A179 - A179
  • [7] The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting
    Santos, Gabriela
    Fabiano, Andre
    Mota, Patricia Caetano
    Rodrigues, Ines
    Carvalho, Diogo
    Melo, Natalia
    Novais-Bastos, Helder
    Alexandre, Andre Terras
    Moura, Conceicao Souto
    Guimaraes, Susana
    Pereira, Jose Miguel
    Carvalho, Andre
    Morais, Antonio
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 83
  • [8] Best tolerated dose of Pirfenidone in patients with idiopathic pulmonary fibrosis
    Agrawal, Neha
    Vaidya, Preyas J.
    Chavhan, Vinod B.
    Lele, Tejashree T.
    Leuppi-Taegtmeyer, Anne
    Leuppi, Joerg D.
    Chhajed, Prashant N.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [9] PIRFENIDONE IS EFFICACIOUS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) WITH MORE PRESERVED LUNG FUNCTION
    Noble, P. W.
    Bradford, W. Z.
    Costabel, U.
    Glaspole, I.
    Glassberg, M. K.
    Gorina, E.
    Kardatzke, D.
    Lancaster, L.
    Lederer, D. J.
    Nathan, S. D.
    Pereira, C.
    Spirig, D.
    Swigris, J. J.
    Valeyre, D.
    Albera, C.
    [J]. THORAX, 2015, 70 : A81 - A81
  • [10] Pirfenidone In Idiopathic Pulmonary Fibrosis In The Real World
    Song, J.
    Park, J. -H.
    Heo, E.
    Kim, D.
    Chung, H. Hee Soon
    Lee, J-K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345